MYCN and neuroblastoma: The integrin αvβ3 was expressed by 61% of microvessels in high-risk neuroblastomas (stage IV and N-Myc-amplified stage III) and 18% of microvessels in low-risk tumors (stages I and II and non-N-Myc amplified stage III).